Go Pro
OTCMKTS:GBLX

GB Sciences (GBLX) Stock Price, News & Analysis

GB Sciences logo
$0.0002 0.00 (0.00%)
As of 09/25/2026

About GB Sciences Stock (OTCMKTS:GBLX)

Advanced

Key Stats

Today's Range
$0.0002
▼
$0.0002
50-Day Range
N/A
52-Week Range
$0.0001
▼
$0.0059
Volume
N/A
Average Volume
42,868 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GB Sciences, Inc. is a biotechnology company focused on developing cannabinoid-based medicines and other cannabis-related therapeutic products. Its activities have included the research, formulation and development of plant-based treatments intended to address conditions such as chronic pain, Parkinson’s disease and other neurological disorders.

The company has also pursued opportunities in the medical cannabis industry, including cannabis cultivation, processing and product development. Through its research programs, GB Sciences has worked on standardized cannabinoid formulations designed to provide consistent therapeutic profiles.

GB Sciences has historically operated through cannabis and biotechnology initiatives in the United States, including projects associated with Louisiana. Publicly available information about its current operations, product availability and leadership is limited, and the company’s business activities may have changed over time.

AI Generated. May Contain Errors.

Receive GBLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GB Sciences and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GBLX Stock News Headlines

GB Sciences Inc.
GB Sciences Delays Filing of Quarterly Report
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
GB Sciences Delays Filing of Quarterly Report
GB Sciences, Inc. (GBLX) - Yahoo Finance
GB Sciences Reports Delay in Quarterly Filing
GB Sciences, Inc. (GBLX) stock forecast and price target
GB Sciences Inc (GBLX)
See More Headlines

GBLX Stock Analysis - Frequently Asked Questions

GB Sciences' stock was trading at $0.0005 at the start of the year. Since then, GBLX stock has decreased by 60.0% and is now trading at $0.0002.

GB Sciences, Inc. (OTCMKTS:GBLX) announced its earnings results on Monday, November, 14th. The company reported ($0.04) earnings per share for the quarter.

Shares of GBLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GB Sciences investors own include Canopy Growth (CGC), 22nd Century Group (XXII), NVIDIA (NVDA), Unrivaled Brands (TRTC), TREES (CANN), Aurora Cannabis (ACB) and Meta Platforms (META).

Company Calendar

Last Earnings
11/14/2016
Today
9/26/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:GBLX
CIK
1165320
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (OTCMKTS:GBLX) was last updated on 9/26/2026 by MarketBeat.com Staff.
From Our Partners